The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3
Open accessAbstract
Coxsackievirus B3 (CVB3) infections induce myocarditis in humans and mice. Little is known about the molecular characteristics of CVB3 that activate the cellular immunity responsible for cardiac inflammation. Previous experiments have identified an antibody escape mutant (H310A1) of a myocarditic variant of CVB3 (H3) that attenuates the myocarditic potential of the virus in mice in spite of ongoing viral replication in the heart. We have cloned full-length infectious cDNA copies of the viral genome of both the wild-type myocarditic H3 variant of CVB3 and the antibody escape mutant H310A1. Progeny viruses maintained the myocarditic and attenuated myocarditic potential of the parent viruses, H3 and H310A1. The full sequence of the H3 viral cDNA is reported and compared with those of previously published CVB3 variants. Comparison of the full sequences of H3 and H310A1 viruses identified a single nonconserved mutation (A to G) in the P1 polyprotein region at nucleotide 1442 resulting in an asparagine-to-aspartate mutation in amino acid 165 of VP2. This mutation is in a region that corresponds to the puff region of VP2. Nucleotide 1442 of the H3 and H310A1 cDNA copies of the viral genome was mutated to change amino acid 165 of VP2 to aspartate and asparagine, respectively. The presence of asparagine at amino acid 165 of VP2 is associated with the myocarditic phenotype, while an aspartate at the same site reduces the myocarditic potential of the virus. In addition, high-level production of tumor necrosis factor alpha by infected BALB/c monocytes is associated with asparagine at amino acid 165 of VP2 as has been previously demonstrated for the H3 virus. These findings identify potentially important differences between the H3 variant of CVB3 and other previously published CVB3 variants. In addition, the data demonstrate that a point mutation in the puff region of VP2 can markedly alter the ability of CVB3 to induce myocarditis in mice and tumor necrosis factor alpha secretion from infected BALB/c monocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histochemistry: Theoretical and Applied
(1953) · Journal of the American Medical Association · doi:10.1001/jama.1953.02940280072039 · Cited by 7,021
Structure of a human common cold virus and functional relationship to other picornaviruses
Rossmann, M. G., Arnold, E., Erickson, J. W., Frankenberger, E. A., Griffith, J. P., Hecht, H.-J., Johnson, J. E., Kamer, G., Luo, M., Mosser, A. G., et al. (1985) · Nature · doi:10.1038/317145a0 · Cited by 1,426
Three-Dimensional Structure of Poliovirus at 2.9 Å Resolution
Hogle, J. M., Chow, M., & Filman, D. J. (1985) · Science · doi:10.1126/science.2994218 · Cited by 1,260
Jf, W. (1980) · PubMed Central · Cited by 799
Differential Regulation of Murine T Lymphocyte Subsets
Fitch, F. W., McKisic, M. D., Lancki, D. W., & Gajewski, T. F. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.000333 · Cited by 341
Involvement of T Lymphocytes in the Pathogenesis of Coxsackie Virus B3 Heart Disease
Woodruff, J. F., & Woodruff, J. J. (1974) · The Journal of Immunology · doi:10.4049/jimmunol.113.6.1726 · Cited by 315
Antigenic Structure of Polioviruses of Serotypes 1, 2 and 3
Minor, P. D., Ferguson, M., Evans, D. M. A., Almond, J. W., & Icenogle, J. P. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-7-1283 · Cited by 305
Sherry, B., Mosser, A. G., Colonno, R. J., & Rueckert, R. R. (1986) · Journal of Virology · doi:10.1128/jvi.57.1.246-257.1986 · Cited by 299
Borrow, P., Evans, C. F., & Oldstone, M. B. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.1059-1070.1995 · Cited by 291
Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55)
Bergelson, J. M., Mohanty, J. G., Crowell, R. L., St John, N. F., Lublin, D. M., & Finberg, R. W. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1903-1906.1995 · Cited by 278
Cited by
Badorff, C., Lee, G.-H., Lamphear, B. J., Martone, M. E., Campbell, K. P., Rhoads, R. E., & Knowlton, K. U. (1999) · Nature Medicine · doi:10.1038/6543 · Cited by 575
Self-citationEvidence of recombination among enteroviruses
Santti, J., Hyypiä, T., Kinnunen, L., & Salminen, M. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8741-8749.1999 · Cited by 259
Fluoxetine is a potent inhibitor of coxsackievirus replication
Zuo, J., Quinn, K. K., Kye, S., Cooper, P., Damoiseaux, R., & Krogstad, P. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00983-12 · Cited by 104
Autoimmune Myocarditis, Valvulitis, and Cardiomyopathy
Myers, J. M., Fairweather, D., Huber, S. A., & Cunningham, M. W. (2013) · Current Protocols in Immunology · doi:10.1002/0471142735.im1514s101 · Cited by 63
Self-citationRoberts, B. J., Dragon, J. A., Moussawi, M., & Huber, S. A. (2012) · Biology of Sex Differences · doi:10.1186/2042-6410-3-25 · Cited by 54
Self-citation
Metadata
- Authors
- Knowlton, K. U., Jeon, E. S., Berkley, N., Wessely, R., & Huber, S.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 1996-11
- Volume
- 70
- Issue
- 11
- Pages
- 7811-7818
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2152072371
- Cited by
- 261
- References
- 39
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. https://app.cochat.ai/papers/10.1128/jvi.70.11.7811-7818.1996
- The paper
- Knowlton, K. U., Jeon, E. S., Berkley, N., Wessely, R., & Huber, S. (1996). A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. Journal of Virology. https://doi.org/10.1128/jvi.70.11.7811-7818.1996
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.